Thus, these results suggest that tissue TRX levels are a good noninvasive marker of oxidative stress in patients with COPD and can be used to stratify patients with COPD for the identification of patient subpopulations who will benefit from antioxidant-targeting treatments. This evidence concerns the gene TXN and chronic obstructive pulmonary disease.